Zhiyuan Tan
PhD candidate / contract
- Name
- Mr. Z. Tan MSc
- Telephone
- 071 5272727
- z.tan@lacdr.leidenuniv.nl
The aim of my PhD project is to optimize dosing in oncology patients by analyzing available pharmacokinetic and pharmacodynamic data from routine clinical practice, using different modeling and simulation approaches. Ultimately these efforts will lead to optimized and individualized cancer treatment with optimal efficacy, reduced toxicity and cost-saving
PhD candidate / contract
- Faculty of Science
- Leiden Academic Centre for Drug Research
- LACDR/Pharmacology
PhD candidate
- Faculty of Science
- Leiden Academic Centre for Drug Research
- LACDR/Pharmacology
Contact
- Tan Z., Völler S., Sancho‐Araiz A., Knibbe C.A.J. & Moes D.J.A.R. (2025), A systematic evaluation of the dosing regimens for approved targeted therapies and immune checkpoint inhibitors in metastatic renal cell carcinoma from a project OPTIMUS perspective, The Journal of Clinical Pharmacology : .
- Tan Z., Völler S., Yin A., Rieborn A., Gelderblom H., Hulle T. van der, Knibbe C.A.J. & Moes D.J.A.R. (2025), Model-informed dose optimization of pazopanib in real-world patients with cancer, Clinical Pharmacokinetics 64(5): 715-728.
- Tan Z., Völler S., Yin A., Rieborn A., Gelderblom A.J., Hulle T. van der, Knibbe C.A.J. & Moes D.J.A.R. (2024), Population pharmacokinetics of cabozantinib in metastatic renal cell carcinoma patients: towards drug expenses saving regimens, Clinical Pharmacokinetics 63(6): 857-869.